+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Endoscopic Vessel Harvesting Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon

    Report

  • 112 Pages
  • June 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4896093
UP TO OFF until Jun 30th 2023
Endoscopic vessel harvesting (EVH) is a surgical technique that is used for patients with coronary artery disease. Its is recommended as a bypass to reroute blood around blocked arteries to restore and improve blood flow and oxygen to the heart. To create the bypass graft healthy blood vessels are harvested from another part of the body, often from the patient's leg or arm.

The key factors driving the growth of the Endoscopic Vessel Harvesting market include the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. However, the availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH may hinder the growth of this market to a certain extent.

Key Market Trends

Coronary Artery Disease segment is expected to cover a large share of the market

Coronary artery disease (CAD) is the leading cause of death and disability and has major impact on developing and developed nations. CAD is the most common serious chronic illness that evolves over years but remains undiagnosed until it presents with life-threatening situations. It is the most common preventable non-communicable disease.

According to a report by Gregory A. Roth et al. published in Journal of the American College of Cardiology 2017, there were around 17.92 million deaths in 2015, with CAD being the leading cause of death. As a result of increasing number of CAD cases, the demand for treatment involving Endoscopic Vessel Harvesting is expected to increase, helping the market grow.

United States Holds the Largest Share of the Market

In the United States (US), Cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 840,678 deaths in the US in 2016, as per American Heart Association, making it the leading cause of death in the US. Coronary heart disease accounted for approximately 13% of deaths in the US in 2016, causing 363,452 deaths. This huge burden has increased the demand for effective cardiovascular treatments.

The US having a well-structured healthcare system attracts the global players, and hence enjoys the presence of almost all of them. Hence high demand is met by the presence of global players, which is helping the growth of the market in this region

Competitive Landscape

Majority of the Endoscopic Vessel Harvesting instruments and systems are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Global Burden of Cardiovascular Diseases
4.2.2 Growing Preference for Minimally Invasive Harvesting Procedures
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Methods
4.3.2 Poor Reimbursement Scenario
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 EVH Systems
5.1.2 Endoscopes
5.1.3 Accessories
5.2 By Usability
5.2.1 Disposable
5.2.2 Reusable
5.3 By Application
5.3.1 Coronary Artery Disease (CAD)
5.3.2 Peripheral Artery Disease (PAD)
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Getinge AB
6.1.2 Terumo Corporation
6.1.3 Livanova PLC
6.1.4 KARL STORZ SE & Co. KG
6.1.5 Saphena Medical
6.1.6 Medical Instruments Spa
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Getinge AB
  • Terumo Corporation
  • Livanova PLC
  • KARL STORZ SE & Co. KG
  • Saphena Medical
  • Medical Instruments Spa

Methodology

Loading
LOADING...